Predictors of recurrent ischemic events and death in unstable coronary artery disease after treatment with combination antithrombotic therapy

American Heart Journal

Volumn 139, Issue 6, 2000, Pages 962-970

  Cohen, Marc ^a,g   Stinnett, Sandra S ^b   Weatherley, Beth D ^b   Gurfinkel, Enrique P ^c   Fromell, Gregg J ^d   Goodman, Shaun G ^e   Fox, Keith A A ^f   Califf, Robert M ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c Inst de Cardiologia y Cirugia   (Argentina)

^d SANOFI   (France)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^g HAHNEMANN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ENOXAPARIN; HEPARIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; ST SEGMENT ELEVATION;

EID: 0034129827     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1067/mhj.2000.106915     Document Type: Article

References (60)

1. Farhi JI, Cohen M, Fuster V. The broad spectrum of unstable angina pectoris and its implications for future controlled trials. Am J Cardiol 1986;58:547-50.
2. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. N Engl J Med 1996;335:775-82.
3. FRagmin during Instability in Coronary artery disease (FRISC) study group. Low molecular weight heparin during instability in coronary artery disease. Lancet 1996;347:561-8.
4. Cohen M, Demers C, Gurfinkel EP, et al, for the Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events Study Group. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. N Engl J Med 1997;337:447-52.
5. The Platelet Receptor Inhibition in ischemic Syndrome Management (PRISM) study investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 1998;338:1498-505.
6. The Platelet Receptor Inhibition in ischemic Syndrome Management in Patients Limited by Unstable Signs and symptoms (PRISM-PLUS) study investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 1998;338:1488-97.
7. The PURSUIT trial investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436-43.
8. FRagmin and fast revascularization during Instability in Coronary artery disease (FRISC II) investigators. Long-term low-molecular-mass heparin in unstable coronary artery disease: FRISC II prospective randomized multicenter study. Lancet 1999;354:701-7.
9. Antman EM, McCabe CH, Gurfinkel EP, et al, for the TIMI-11B investigators. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 11B trial. Circulation 1 999;100:1593-601.
10. Antman EM, Cohen M, Radley D, et al, for the TIMI-11B (Thrombolysis in Myocardial Infarction) and ESSENCE (Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-wave Coronary Events) investigators. Assessment of the treatment effect of enoxaparin for unstable angina/non-Q wave myocardial infarction: TIMI-11B-ESSENCE meta-analysis. Circulation 1999;100:1602-8.
11. Cohen M, Bigonzi F, Le Louer V, et al. One year follow-up of the ESSENCE trial (enoxaparin versus heparin in unstable angina and non Q wave myocardial infarction) [abstract]. J Am Coll Cardiol 1998;31(Suppl-A):79A.
12. Armstrong PW, Fu Y, Chang W-C, et al. Acute coronary syndromes in the GUSTO-IIb trial: prognostic insights and impact of recurrent ischemia. Circulation 1998;98:1860-8.
13. van Domburg RT, van Miltenberg-van Zijl AJ, Veerhoek RJ, et al. Unstable angina: good long-term outcome after a complicated early course. J Am Coll Cardiol 1998;31:1534-9.
14. Gazes PC, Mobley EM Jr, Faris HM Jr, et al. Preinfarctional (unstable) angina-a prospective study-ten year follow-up. Circulation 1973;48:331-7.
15. National Cooperative Study Group to Compare Surgical and Medical Therapy. Unstable angina pectoris. Am J Cardiol 1978;42:839-48.
16. Braunwald E. Unstable angina: a classification. Circulation 1989;80:410-4.
17. Cannon CP, McCabe CH, Stone PH, et al. The electrocardiogram predicts one-year outcome of patients with unstable angina and non-Q wave myocardial infarction: results of the TIMI III registry ECG ancillary study. J Am Coll Cardiol 1997;30:133-40.
18. Calvin JE, Klein LW, VandenBerg BJ, et al. Risk stratification in unsta-ble angina, prospective validation of the Braunwald classification. JAMA 1995;273:136-41.
19. Beck JR, Shultz EK. The use of relative operating characteristic (ROC) curves in test performance evaluation. Arch Pathol Lab Med 1986;110:13-20.
20. Campeau L. Grading of angina pectoris. Circulation 1976;54:522-3.
21. Master AM, Dack S, Grishman A, et al. Acute coronary insufficiency: an entity. J Mt Sinai Hosp 1947;14:8-23.
22. Wood P. Acute and subacute coronary insufficiency. BMJ 1961;1:1779-82.
23. Fischl SJ, Herman MV, Gorlin R. The intermediate coronary syndrome: clinical, angiographic and therapeutic aspects. N Engl J Med 1973;288:1193-8.
24. Neill WA, Wharton TP Jr, Fluri-Lundeen J, et al. Acute coronary insufficiency: coronary occlusion after intermittent ischemic attacks. N Engl J Med 1980;302:1157-62.
25. Kimbiris D, Iskandrian A, Saras H, et al. Rapid progression of coronary stenosis in patients with unstable angina pectoris selected for coronary angioplasty. Cathet Cardiovasc Diagn 1984;10:101-14.
26. Fulton M, Lutz W, Donald KW, et al. Natural history of unstable angina. Lancet 1972;1:860-5.
27. Ouyang P, Brinker JA, Mellits ED, et al. Variables predictive of successful medical therapy in patients with unstable angina: selection by multivariate analysis from clinical, electrocardiographic, and angiographic evaluations. Circulation 1984;70:367-76.
28. Launbjerg J, Fruergaard P, Madsen JK, et al. Ten year mortality in patients with suspected acute myocardial infarction. BMJ 1994;308:1196-9.
29. Maseri A. Pathogenetic classifications of unstable angina as a guideline to individual patient management and prognosis. Am J Med 1986;80(Suppl 4C):48-55.
30. Merlini PA, Bauer KA, Oltrona L, et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994;90:61-8.
31. Ardissino D, Merlini PA, Gamba G, et al. Thrombin activity and early outcome in unstable angina pectoris. Circulation 1996;93:1634-9.
32. Braunwald E, Mark DB, Jones RH, et al. Unstable angina: diagnosis and management. Clinical Practice Guideline number 10, AHCPR Publication No. 94-0602. Washington, DC: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services; 1994.
33. Boersma E, Pieper KS, Steyerberg EW, et al, for the PURSUIT investigators. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation: results from an international trial of 9461 patients [abstract]. J Am Coll Cardiol 1999;33:359A.
34. Willerson JT, Parkey RW, Bonte FJ, et al. Technetium stannous pyrophosphate myocardial scintigrams in patients with chest pain of varying etiology. Circulation 1975;51:1046-52.
35. Armstrong PW, Chiong MA, Parker JO. The spectrum of unstable angina: prognostic role of serum creatine kinase determination. Am J Cardiol 1982;49:1 849-52.
36. Alexander JH, Sparapani RH, Mahaffey KW, et al, for the PURSUIT steering committee. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. JAMA 2000;283:347-53.
37. Stubbs P, Collinson P, Moseley D, et al. Prospective study of the role of cardiac troponin T in patients admitted with unstable angina. BMJ 1996;313:262-4.
38. Lindahl B, Venge P, Wallentin L, for the FRISC study group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation 1996;93:1651-7.
39. Hamm CW, Goldmann BU, Heeschen C, et al. Emergency room triage of patients with acute chest pain by means of rapid testing for cardiac troponin T or troponin I. N Engl J Med 1997;337:1648-53.
40. Luscher MS, Thygesen K, Ravkilde J, et al, for the TRIM STUDY GROUP. Applicability of cardiac troponin T and I for early risk stratification in unstable coronary artery disease. Circulation 1997;96:2578-85.
41. Galvani M, Ottani F, Ferrini D, et al. Prognostic influence of elevated values of cardiac troponin I in patients with unstable angina. Circulation 1997;95:2053-9.
42. Polanczyk CA, Lee TH, Cook EF, et al. Cardiac troponin I as a predictor of major cardiac events in emergency department patients with acute chest pain. J Am Coll Cardiol 1998;32:8-14.
43. Newby LK, Christenson RH, Ohman EM, et al. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. Circulation 1998;98:1853-9.
44. Lewis HD Jr, Davis JW, Archibald DG, et al. Protective effects of aspirin against myocardial infarction and death in men with unstable angina. N Engl J Med 1983;309:396-403.
45. Eisenberg PR, Kenzora JL, Sobel BE, et al. Relation between ST segment shifts during ischemia and thrombin activity in patients with unstable angina. J Am Coll Cardiol 1991;18:898-903.
46. Lee HS, Cross SJ, Rawles JM, et al. Patients with suspected myocardial infarction who present with ST depression. Lancet 1993;342:1204-7.
47. Savonitto S, Ardissino D, Granger CB, et al. Prognostic value of the admission electrocardiogram in acute coronary syndromes. JAMA 1999;281:707-13.
48. Cohen M, Hawkins L, Greenberg S, et al. Usefulness of ST-segment changes in greater than or equal to 2 leads on the emergency room electrocardiogram in either unstable angina pectoris or non-Q-wave myocardial infarction in predicting outcome. Am J Cardiol 1991;67:1368-73.
49. Cohen M, Fox K, Turpie AGG, et al, on behalf of the ESSENCE group. Patient populations and clinical practices: inter-region differences observed in the international ESSENCE Trial [abstract]. Eur Heart J 1997;12(Suppl):166.
50. Gurfinkel E, on behalf of the Ushuaia Conference Group. Current treatment and future prospects for the management of acute coronary syndromes. Consensus recommendations of the 1997 Ushuaia Conference, Tierra del Fuego, Argentina. Clin Drug Invest 1998;15:368-80.
51. Van deWerf F, Topol EJ, Lee KL, et al, for the GUSTO investigators. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries. Results from the GUSTO trial. JAMA 1995;273:1586-91.
52. Adams PC, Skinner JS, Cohen M, et al, and the Antithrombotic Therapy in Acute Coronary Syndromes Research Group. Acute coronary syndromes in the United States and United Kingdom: a comparison of approaches. Clin Cardiol 1998;21:348-52.
53. Lee KL, Woodlief LH, Topol EJ, et al, for the GUSTO-1 investigators. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41,021 patients. Circulation 1995;91:1659-68.
54. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
55. Toss H, Lindahl B, Siegbahn A, et al, for the FRISC Study Group. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. Circulation 1997;96:4204-10.
56. Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol 1998;31:1460-5.
57. Gottlieb SO, Weisfeldt ML, Ouyang P, et al. Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina. N Engl J Med 1986;314:1214-9.
58. Montalescot G, Philippe F, Ankri A, et al and the French investigators of the ESSENCE trial. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. Circulation 1998;98:294-9.
59. Katz DA, Griffith JL, Beshansky JR, et al. The use of empiric clinical data in the evaluation of practice guidelines for unstable angina. JAMA 1996;276:1568-74.
60. Jacobs DR Jr, Kroenke C, Crow R, et al. PREDICT-a simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota Heart Survey. Circulation 1999;100:599-607.